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Abstract Measuring the accuracy of diagnostic tests is crucial in many application areas including medicine, machine
learning and credit scoring. The receiver operating characteristic (ROC) curve is a useful tool to assess the ability of a
diagnostic test to discriminate among two classes or groups. In practice, multiple diagnostic tests or biomarkers may be
combined to improve diagnostic accuracy, e.g. by maximizing the area under the ROC curve. In this paper we present
Nonparametric Predictive Inference (NPI) for best linear combination of two biomarkers, where the dependence of the two
biomarkers is modelled using parametric copulas. NPI is a frequentist statistical method that is explicitly aimed at using few
modelling assumptions, enabled through the use of lower and upper probabilities to quantify uncertainty. The combination
of NPI for the individual biomarkers, combined with a basic parametric copula to take dependence into account, has good
robustness properties and leads to quite straightforward computation. We briefly comment on the results of a simulation
study to investigate the performance of the proposed method in comparison to the empirical method. An example with data
from the literature is provided to illustrate the proposed method, and related research problems are briefly discussed.
Keywords Bivariate diagnostic tests, copulas, diagnostic accuracy, lower and upper probabilities, nonparametric predictive
inference, ROC curve.
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1. Introduction
Measuring the accuracy of diagnostics tests is crucial in many application areas including medicine and health care.
The Receiver Operating Characteristic (ROC) curve is a popular statistical tool for describing the performance of
diagnostic tests. The area under the ROC curve (AUC) is often used as a measure of the overall performance of the
diagnostics test [18]. However, one diagnostic test may not be enough to draw a useful conclusion, thus in practice
multiple diagnostic tests or biomarkers may be combined to improve diagnostic accuracy [19]. There are several
approaches in the literature which aim to find the best linear combination of biomarkers in order to maximize the
area under the ROC curve, and thus to improve the diagnostic accuracy, see e.g. [13, 15, 17, 19]. These approaches
either assume an underlying distribution or focus on estimation. In this paper, we instead use nonparametric
predictive inference (NPI) for this setting with two biomarkers. NPI [1, 4] is a frequentist statistics method which
explicitly considers prediction, which is an attractive alternative to the classical estimation perspectives in this
context as one is mainly interested in the performance of a diagnostic test for a future patient or healthy person to
whom the test is applied.
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We first present the basic concepts and notation used in this paper. Let D be a binary variable describing the
disease status, i.e. D = 1 for disease and D = 0 for non-disease. Suppose that the result of a diagnostic test, X , is
a continuous random quantity, such that large values of X are considered more indicative of disease. We assume
that we have diagnostic test results for two groups, the first consisting of people known to have the disease, often
referred to as ‘patients’ or ‘cases’, and the second consisting of people known not to have the disease, referred to as
‘non-patients’ or ‘controls’. Test results for members of these groups are denoted with superscripts corresponding
to the value of the disease status D, so X1 for the disease group and X0 for the non-disease group. The Receiver
Operating Characteristic (ROC) curve is defined through the combination of False Positive Fraction (FPF) and True
Positive Fraction (TPF) over all values of the threshold c, i.e. ROC = f(FPF(c);TPF(c)); c 2 ( 1;1)g, where
FPF(c) = P (X0 > cjD = 0) and TPF(c) = P (X1 > cjD = 1). An ideal test completely separates the patients with
and without the disease for a threshold c, i.e. FPF(c) = 0 and TPF(c) = 1. A useless or uninformative test fails to
distinguish between patients and non-patients for all thresholds c, which would be reflected by FPF(c) = TPF(c)
for all thresholds c [18].
In many cases, a single numerical value or summary may be useful to represent the accuracy of a diagnostic
test or to compare two or more ROC curves [18]. A useful summary is the area under the ROC curve, AUC. The
AUC measures the overall performance of the diagnostic test. Higher AUC values indicate more accurate tests,
with AUC = 1 for ideal tests and AUC = 0:5 for uninformative tests. The AUC is equal to the probability that the
test results from a randomly selected pair of diseased and non-diseased subjects are correctly ordered [18], i.e.
AUC = P

X1 > X0

.
To estimate the ROC curve for diagnostic tests with continuous results, the nonparametric empirical method
is popular due to its flexibility to adapt fully to the available data. This method yields the empirical ROC curve,
which will be considered in this paper for comparison to the NPI method which we introduce. Suppose that we
have test data on n1 individuals from a disease group and n0 individuals from a non-disease group, denoted by
fx1i ; i = 1; : : : ; n1g and fx0j ; j = 1; : : : ; n0g, respectively. Throughout this paper we assume that the two groups are
fully independent, meaning that no information about any aspect related to one group contains information about
any aspect of the other group. For the empirical method, these observations per group are assumed to be realisations
of random quantities that are identically distributed as X1 and X0, for the disease and non-disease groups,
respectively. The empirical estimator of the ROC is[ROC =
ndFPF(c);dTPF(c) ; c 2 ( 1;1)o with dTPF(c) =
1
n1
Pn1
i=1 1

x1i > c
	
and dFPF(c) = 1n0 Pn0j=1 1x0j > c	, where 1fAg is the indicator function which is equal to
1 if A is true and 0 else. The empirical estimator of the AUC is given by[AUC = 1n1n0
Pn0
j=1
Pn1
i=1 1

x1i > x
0
j
	
[18].
In this paper we consider the linear combination of results of two diagnostic tests applied to the individuals
from the disease and non-disease groups. Let XD and Y D be continuous random quantities representing the
results of the two diagnostic tests for disease group D = 0; 1. Consider a weighted average of the two test
results, TD(XD; Y D) = XD + (1  )Y D, where  2 [0; 1] and the coefficient  is chosen to maximize the
AUC associated with the composite score TD, where the ROC curve is used with the combined test score T 1 for
all patients and T 0 for all non-patients [19].
Suppose that we have two test results for each of the n1 individuals from a disease group and n0 individuals
from a non-disease group, we denote these observations by

(x1i ; y
1
i ); i = 1; :::; n1
	
and

(x0j ; y
0
j ); j = 1; :::; n0
	
,
respectively. Consider a weighted average of the test results, t1i = x
1
i + (1  )y1i for the disease group and
t0j = x
0
j + (1  )y0j for the non-disease group, where  2 [0; 1]. The empirical estimator of the ROC curve
corresponding to the combined test score is
[ROC =
ndFPF(c);dTPF(c) ; c 2 ( 1;1)o (1)
with
dTPF(c) = 1
n1
n1X
i=1
1ft1i > cg ; dFPF(c) = 1n0
n0X
j=1
1ft0j > cg
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The AUC associated with TD(XD; Y D) is [19]
[AUC = 1
n1n0
n0X
j=1
n1X
i=1
1

x1i + (1  )y1i > x0j + (1  )y0j
	
(2)
It is best to use that value of  which maximizes the AUC in Equation (2), we denote this by ^.
This paper is organized as follows. Section 2 provides a brief introduction to NPI for ROC analysis with a single
biomarker. Section 3 reviews the combination of NPI for marginals with a parametric copula [6] and applies this
method to the bivariate diagnostic test setting introduced above. Section 4 briefly discusses initial insights from a
simulation study investigating the performance of our method, followed by an example of the application of our
method to data from the literature. Some concluding remarks are provided in Section 5.
2. NPI for ROC analysis
In this paper we present Nonparametric Predictive Inference (NPI) for best linear combination of two biomarkers,
where the dependence of the two biomarkers is modelled using parametric copulas. NPI is a frequentist statistical
method that is explicitly aimed at using few modelling assumptions, enabled through the use of lower and upper
probabilities to quantify uncertainty. NPI is based on the assumption A(n), proposed by Hill [12], which gives a
direct conditional probability for a future real-valued random quantity, conditional on observed values of n related
random quantities. Effectively, A(n) implies that the rank of the future observation among the observed values is
equally likely to have each possible value 1; : : : ; n+ 1. Hence, this assumption is that the next observation has
probability 1=(n+ 1) to be in each interval of the partition of the real line as created by the n observations. We
assume here, for ease of presentation, that there are no tied observations (these can be dealt with by assuming that
such observations differ by a very small amount, a common method to break ties in statistics).
Inferences based on A(n) are predictive and nonparametric, and can be considered suitable if there is hardly any
knowledge about the random quantity of interest, other than the n observations, or if one does not want to use any
such further information in order to derive at inferences that are strongly based on the data. The assumption A(n) is
not sufficient to derive precise probabilities for many events of interest, but it provides bounds for probabilities via
the ‘fundamental theorem of probability’ [10], which are lower and upper probabilities [1, 2]. Augustin and Coolen
[1] proved that NPI has attractive inferential properties, it is also exactly calibrated from frequentist statistics
perspective [14], which allows interpretation of the NPI lower and upper probabilities as bounds on the long-term
ratio with which the event of interest occurs upon repeated application of this statistical procedure.
NPI has been presented for assessing the accuracy of a classifier’s ability to discriminate between two groups for
binary data [7], for diagnostic tests with ordinal observations [11] and with real-valued observations [8]. NPI has
also been presented for three-group ROC surfaces, with real-valued observations [9] and with ordinal observations
[5], to assess the ability of a diagnostic test to discriminate among three ordered classes or groups.
We briefly introduce NPI for diagnostic accuracy, following Coolen-Maturi et al. [8]. The NPI method is different
from the nonparametric empirical method as it is explicitly predictive, considering a single next future observation
given the past observations, instead of aiming at estimation for an entire assumed underlying population. In NPI
uncertainty is quantified by lower and upper probabilities for events of interest. The NPI lower and upper ROC
curves, and the corresponding lower and upper AUC, have been derived by Coolen-Maturi et al. [8], corresponding
to the assumptions A(n1) for the disease group and A(n0) for the non-disease group, where the inferences consider
one future patient from each group.
Suppose that X1i ; i = 1; : : : ; n1; n1 + 1, are continuous and exchangeable random quantities from the disease
group and X0j ; j = 1; : : : ; n0; n0 + 1 are continuous and exchangeable random quantities from the non-disease
group, where X1n1+1 and X
0
n0+1
are the next observations from the disease and non-disease groups following
n1 and n0 observations, respectively. As mentioned before, we assume that both groups are fully independent.
Let x11 < : : : < x1n1 be the ordered observed values for the first n1 individuals from the disease group and
x01 < : : : < x
0
n0 the ordered observed values for the first n0 individuals from the non-disease group. For ease of
notation, let x10 = x00 =  1 and x1n1+1 = x0n0+1 = 1. We assume that there are no ties in the data. The NPI lower
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and upper ROC curves are [8]
ROC =
 
FPF(c);TPF(c)

; c 2 ( 1;1)	 (3)
ROC =
 
FPF(c);TPF(c)

; c 2 ( 1;1)	 (4)
where
TPF (c) =P (X1n1+1 > c) =
Pn1
i=1 1

x1i > c
	
n1 + 1
(5)
TPF (c) =P (X1n1+1 > c) =
Pn1
i=1 1

x1i > c
	
+ 1
n1 + 1
(6)
FPF (c) =P (X0n0+1 > c) =
Pn0
j=1 1

x0j > c
	
n0 + 1
(7)
FPF (c) =P (X0n0+1 > c) =
Pn0
j=1 1

x0j > c
	
+ 1
n0 + 1
(8)
where P and P are NPI lower and upper probabilities [1]. It is easily seen that FPF(c)  dFPF(c)  FPF(c) and
TPF(c)  dTPF(c)  TPF(c) for all c, which implies that the empirical ROC curve is bounded by the NPI lower
and upper ROC curves [8].
The NPI lower and upper AUC, which are the areas under the NPI lower and upper ROC curves given in (3) and
(4), respectively, are also equal to the NPI lower and upper probabilities for the event that the test result for the next
individual from the disease group is greater than the test result for the next individual from the non-disease group,
and given by [8]
AUC =P
 
X1n1+1 > X
0
n0+1

=
1
(n1 + 1)(n0 + 1)
n0X
j=1
n1X
i=1
1

x1i > x
0
j
	
(9)
AUC =P
 
X1n1+1 > X
0
n0+1

=
1
(n1 + 1)(n0 + 1)
"
n0X
j=1
n1X
i=1
1

x1i > x
0
j
	
+ n1 + n0 + 1
#
(10)
It is interesting to notice that the imprecision in these lower and upper AUCs, AUC AUC = n1+n0+1(n1+1)(n0+1) ,
depends only on the sample sizes n0 and n1.
3. NPI with parametric copula for bivariate diagnostic tests
In this section we present NPI for the weighted average of the two diagnostic tests to optimize the diagnostic
accuracy with consideration of the dependence structure through the use of a parametric copula. Taking into
account the dependence between two diagnostic test results for the same person is important when considering
the combination of the bivariate test results, as it can influence the accuracy of detection of diseases [3]. We use the
recently introduced predictive inference method for bivariate data which consists of NPI for each of the marginals
in combination with a parametric copula, where the parameter is estimated using the available data [6]. This is a
relatively straightforward method for prediction of a bivariate random quantity, where imprecision resulting from
the use of NPI for the marginals provides robustness with regard to the assumed copula for small sample sizes. We
introduce this method here immediately with application to the linear combination of two diagnostic test results.
For more details on this predictive method we refer to Coolen-Maturi et al. [6].
Consider a bivariate random quantity of diagnostic test results, (X;Y ), let (XDnD+1; Y
D
nD+1
) be the next future
bivariate random quantity of diagnostic test results and let TDnD+1 = X
D
nD+1
+ (1  )Y DnD+1, with  2 [0; 1],
be the weighted average of the two test results for a future person from the group with disease status D. For
the disease group, the lower probability for the event that the sum of the next future observations will exceed a
Stat., Optim. Inf. Comput. Vol. 6, September 2018
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particular threshold  is
S1c(t) = P (T
1
n1+1 > ) =
X
(i;l)2L1t
h1il( b1) (11)
with L1t = f(i; l) : x1i 1 + (1  )y1l 1 > g, and the corresponding upper probability is
S
1
c(t) = P (T
1
n1+1 > ) =
X
(i;l)2U1t
h1il( b1) (12)
with U1t = f(i; l) : x1i + (1  )y1l > g, where  2 ( 1;1) and S1c(t) and S
1
c(t) are the lower and upper
survival functions for the sum of the next future observations, T 1n1+1, where dependence is taken into account
as explained next, and a subscript c is added to key notations throughout this chapter to emphasize the use of an
assumed copula.
The quantities h1il( b1) are crucial to this method, as they take the dependence between the two diagnostic test
meausurements for the future person from the disease group into account, as estimated based on the available data
for this group with an assumed parametric copula. They are defined as
h1il( b1) = Pc( eX1n1+1 2  i  1n1 + 1 ; in1 + 1

; eY 1n1+1 2  l   1n1 + 1 ; ln1 + 1

j b1) (13)
for i; l = 1; 2; : : : ; n1 + 1, where Pc(j^1) represents the copula-based probability using a parametric copula, where
^1 is the estimated parameter value for this copula for the disease group. This parameter can be multi-dimensional,
but we will restrict attention later to widely used symmetric parametric copulas with a single parameter. If one uses
a multi-dimensional parameter, the computational aspects of this method remain quite straightforward with only
the estimation of the parameter possibly becoming more complicated. The random quantities eX1n1+1 and eY 1n1+1 are
both uniformly distributed on [0; 1] and they are dependent, with the dependence modelled through the assumed
copula. Note that eX1n1+1 is related to the random quantityX1n1+1 through a transformation based on the assumption
A(n1) for X
1
n1+1
, as explained in detail by Coolen-Maturi et al. [6].
Similarly, for the non-disease group, the lower probability for the event that the sum of the next future
observations will exceed a particular threshold  is
S0c(t) = P (T
0
n0+1 > ) =
X
(j;k)2L0t
h0jk( b0) (14)
with L0t = f(j; k) : x0j 1 + (1  )y0k 1 > g, and the corresponding upper probability is
S
0
c(t) = P (T
0
n0+1 > ) =
X
(j;k)2U0t
h0jk( b0) (15)
with U0t = f(j; k) : x0j + (1  )y0k > g, where  2 ( 1;1) and S0c(t) and S
0
c(t) are the lower and upper
survival functions for the sum of the next future observation, T 0n0+1. The probabilities h
0
jk(
b0) are defined as
h0jk( b0) = Pc( eX0n0+1 2  j   1n0 + 1 ; jn0 + 1

; eY 0n0+1 2  k   1n0 + 1 ; kn0 + 1

j b0) (16)
for j; k = 1; 2; : : : ; n0 + 1 where Pc(j^0) represents the copula-based probability with estimated parameter ^0 for
the non-disease group.
The method used above combines NPI for the marginals with an assumed parametric copula, with its parameter
estimated on the basis of available data [6, 16]. Effectively it requires computation of the (n1 + 1)2 joint
probabilities h1il for the disease group, and the (n0 + 1)
2 joint probabilities h0jk for the non-disease group, for the
assumed parametric copula with estimated parameter value b1 and b0, respectively. These are straightforward to
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compute for commonly used parametric copulas. The parameters can be estimated straightforwardly as well, using
any suitable estimation method, e.g. maximum likelihood estimation [6]. Note that this method is computationally
far easier than the standard method with copula-based models, as through the use of NPI for the marginals there is
no need to simultaneously estimate the marginals and the copula. In the approach outlined above, the transformation
of the marginals is included through the sets L1t ; U1t ; L0t and U0t in Equations (11), (12), (14) and (15), respectively.
The use of these sets also leads to additional imprecision in the inferences, which provides additional robustness
for the choice of the specific copula.
The NPI lower and upper survival functions from Equations (11), (12), (14) and (15) are used to derive lower
and upper FPF and TPF for the weighted average of the next future observations per group, for different threshold
values , and these are combined to derive the corresponding NPI lower and upper ROC curves. This leads to
the following optimal bounds for the TPF and FPF when considering the dependence structure with the assumed
parametric copula,
TPFc () = S
1
c() = P (T
1
n1+1 > ) =
X
(i;l)2L1t
h1il( b1) (17)
TPFc () = S
1
c() = P (T
1
n1+1 > ) =
X
(i;l)2U1t
h1il( b1) (18)
FPFc () = S
0
c() = P (T
0
n0+1 > ) =
X
(j;k)2L0t
h0jk( b0) (19)
FPFc () = S
0
c() = P (T
0
n0+1 > ) =
X
(j;k)2U0t
h0jk( b0) (20)
The lower and upper ROC curves are again defined to be the optimal bounds for all such curves corresponding to
any pair of survival functions S1c (t) and S0c (t) for T 1n1+1 and T
0
n0+1
in between their respective lower and upper
survival functions, as given by Equations (17) - (20). The ROC curve with copula clearly depends monotonically
on the survival functions. It is easily seen that the optimal bounds based on our method, which are lower and upper
ROC curves, are
ROCc =
 
FPF c(); TPF c()

;  2 ( 1;1)	 (21)
ROCc =
 
FPF c(); TPF c()

;  2 ( 1;1)	 (22)
In order to optimize the diagnostic accuracy of the weighted average of the two future diagnostic test results,
we maximize the area under either the lower or the upper ROC curve, by finding the value of  such that
TDnD+1 = X
D
nD+1
+ (1  )Y DnD+1 maximizes the respective AUC. These lower and upper AUCs are derived
as follows. For each block B1il = f(x; y)jx 2 (x1i 1; x1i ); y 2 (y1l 1; y1l )g, generated by the observed data, let
t1i 1;l 1 = x
1
i 1 + (1  )y1l 1 be the combined weighted value corresponding to the left-bottom corner of
the block, and t1i;l = x
1
i + (1  )y1l the combined weighted value corresponding to the right-top corner of
the block. The same can be defined for each block B0jk = f(x; y)jx 2 (x0j 1; x0j ); y 2 (y0k 1; y0k)g, leading to
t0j 1;k 1 = x
0
j 1 + (1  )y0k 1 and t0j;k = x0j + (1  )y0k. In line with Equations (11) - (16), the lower AUC
and upper AUC associated with the weighted average for the bivariate diagnostic test results with parametric copula
can directly be defined as
AUCc = P (T
1
n1+1 > T
0
n0+1) =
n1+1X
i=1
n1+1X
l=1
h1il(^1)
"
n0+1X
j=1
n0+1X
k=1
1ft0j;k < t1i 1;l 1gh0jk(^0)
#
(23)
AUCc = P (T
1
n1+1 > T
0
n0+1) =
n1+1X
i=1
n1+1X
l=1
h1il(^1)
"
n0+1X
j=1
n0+1X
k=1
1ft0j 1;k 1 < t1i;lgh0jk(^0)
#
(24)
The derivations of these lower and upper probabilities, that is the second equality in each of Equations (23) and
(24), are given in the Appendix. The arguments that these lower and upper probabilities are indeed equal to the
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areas under the lower and upper ROCs, as given in Equations (21) and (22), are identical to the arguments for the
corresponding equalities in Equations (9) and (10) as explained by Coolen-Maturi et al. [8]) and in the PhD thesis
of Muhammed [16]. These lower and upper AUCs are quite easy to maximize by searching over  2 [0; 1], we
denote the value of  which maximizes AUC by ^cL, and the value of  which maximizes AUC by ^
c
U .
4. Simulation and example
We performed a simulation study to investigate the performance of the proposed method against the empirical
method, the details of the simulation study are presented in the PhD thesis by Muhammed [16]. It should be noted
that these simulations took very substantial computation time, because of the need to find maximum values for the
linear combination coefficient  in every run. Compared to this, the computation time required for the use of the
bivariate inference method described in Section 3 was negligible.
We considered several cases, always sampling 10,000 runs in each case and using bivariate Normal distributions
for all (X;Y ), with variances 1 for both X and Y and correlation 0.5. We particularly wished to investigate if the
new method with NPI for the marginals and an assumed parametric copula, with the parameter estimated using
the data, would provide different weights  compared to the empirical method. We applied four commonly used
parametric copulas, namely the Clayton, Frank, Gumbel and Normal copulas [16], the results were very similar
for all of these. The results of the simulations showed that our new method tends to give slightly larger weight
to the variable X or Y for which difference in the means of the Normal distributions for the disease and non-
disease groups is larger. This is a promising feature for the method, although the actual difference in the optimal
weights was relatively small and tended to disappear with increasing sample sizes. Overall, one could say that the
simulation study showed slightly better performance of our method for small sample sizes (up to about 30 for each
group) but that there was no noticeable difference between this method and the empirical method for larger sample
sizes.
One reason for the perhaps somewhat surprising fact that our method, taking into account dependence between
the X and Y variables, did not perform substantially better than the empirical method is likely to be the fact
that we only considered data from bivariate Normal distributions, hence with a linear dependence between the
X and Y variables. Since the weighted linear combination of the X and Y measurements therefore can take
this model dependence into account, there would be less benefit expected from the method taking dependence
into account, in particular also because we only used symmetric parametric copulas. For a clearer perspective of
our general method, it would be necessary to study its performance with different, that is non-linear, underlying
dependence structures. However, this would only be really successful if there is good topic knowledge available
which would guide the choice of parametric copula. We are hopeful of developing our method further by the use of
nonparametric copulas instead of a parametric copula. This will give far more flexibility in dependence structure
that can be taken into account, which will be particularly useful in practical scenarios with possibly complicated,
yet mostly unknown, non-linear dependence between theX and Y variables. This provides a challenging direction
for future research. The PhD thesis by Muhammed [16] contains a first attempt towards combining NPI for the
marginals with a nonparametric, kernel-based, copula, but this work requires further development before it can be
applied to combination of multiple diagnostic tests.
As an example of the application of our method, we use a data set from the literature resulting from a study of
90 pancreatic cancer patients and 51 control patients with pancreatitis [20]. Two serum markers were measured
on these patients, the carbohydrate antigen CA19-9 (biomarker X in our method) and the cancer antigen CA125
(biomarker Y ). The marker values were transformed to a natural logarithmic scale and are displayed in Figure 1.
To make sure that our biomarkers tests results are comparable we used standardized values (i.e. with mean 0 and
variance 1) after the natural logarithmic transformation as inputs to our method. Objectives of this example were
to see if a weighted average of these two biomarkers could provide a better diagnostic quantity than the individual
biomarkers, and to see if the choice of parametric copula in our method would make a substantial difference.
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Figure 1. Pancreatic cancer data set
Using the individual biomarkers only, and the empirical ROC method, biomarker CA19-9 leads to empirical
AUC equal to 0.8614 and biomarker CA125 to empirical AUC equal to 0.7056. Using Equations (9) and (10), the
NPI lower and upper AUC values using only biomarker CA19-9 are 0.8347 and 0.8648, respectively, and when
using only biomarker CA125 these values are 0.6883 and 0.7130, respectively. We applied our method with the
Clayton, Frank, Gumbel and Normal copulas. The optimal lower and upper AUC values for our method, with
corresponding values for , are shown in Table 1.
Copula ^cL AUCc ^
c
U AUCc
Normal 0.7160 0.8306 0.7151 0.8896
Frank 0.7077 0.8324 0.7077 0.8920
Clayton 0.7066 0.8364 0.7061 0.8947
Gumbel 0.7215 0.8301 0.7226 0.8880
Table 1. Lower and upper AUC values and corresponding values of 
These results show that there is very little difference in our method for the four different parametric copulas
considered. In terms of the AUC value, the Clayton copula performs best but differences are mainly only in the
third decimal. These lower and upper AUC values also all bound the AUC value 0.8614 achieved by using only the
best single biomarker CA19-9. For all copulas the performance is, of course, substantially better than for the worst
single biomarker CA125, but we aim at using a weighted combination in order to improve on the best individual
biomarker. We also applied the empirical method for the linear combination of these two biomarkers, this led to
maximum AUC equal to 0:8939 for ^ = 0:7188, which is very close to the upper AUC values achieved by our
method, with only the Clayton copula providing a slightly better upper AUC value. More important for practical
purposes is that the optimal values for  for all these methods are nearly identical. This example only indicates a
hardly noticeable improvement in diagnostic accuracy by combining the two biomarkers over the use of only the
single biomarker CA19-9. One possible reason for this is that taking the weighted average is too restrictive if the
individual biomarkers for the disease group and for the non-disease group have correlations with different signs,
but more importantly our current method with the use of these basic symmetric parametric copulas only considers
linear dependence, which is also taken into account in the empirical combination method. The real benefit of our
method is likely to show for more complex dependence structures, which will require more flexible copulas to be
used, where nonparametric copulas are most likely to be most successful as long as the data sets are suitably large.
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5. Concluding remarks
This paper reported on intermediate results from an ongoing study into generalizing the NPI approach to
multivariate data, in particular considering the use of such methods for bivariate diagnostic tests. The study
has shown that the computational aspects of the method for this application are not a substantial problem, the
computation time was mostly determined by the need to find optimal linear combination coefficients, so not for
the underlying novel statistical methodology which combines NPI for the marginals with an estimated parametric
copula. Simulation studies [16], which we briefly reported, showed a small improvement of our method on the
far simpler empirical method in the case of small data sets, but this advantage disappeared for larger data sets.
However, thus far only scenarios with linear dependences in the underlying data models have been studied, for
which the dependence can be taken into account by the weighted average, also for the empirical method. Real
benefit from our novel statistical method is expected when there are more complex dependence structures, but this
would require either parametric copulas which reflect the dependence structure, and therefore may require detailed
topic knowledge, or the use of flexible nonparametric copulas. We are continuing our research project mainly
focussing on the second of these approaches, that is developing predictive inference methods for bivariate data by
combining NPI for the marginals with nonparametric copulas, which can also be extended to multivariate data of
higher dimension.
In this paper we compared our NPI method with an assumed parametric copula to the basic empirical method
described in Section 1. Muhammad [16] also considers a more direct NPI method where, for given value of , only
the weighted averages of the test results, t1i and t
0
j , are used, and NPI is applied per group to provide predictive
inference on the weighted average for a future individual from each group. This approach does not attempt to learn
dependence between the two diagnostic tests applied to the same person, and it is as simple to apply as the empirical
method. Simulation studies [16] showed that the results of that direct NPI method are very close the results of the
empirical method, which will also be the case if scenarios with non-linear dependences would be investigated, in
which case our new method with the use of a copula is expected to perform substantially better.
In principle our approach can be similarly applied to combination of biomarkers for diagnostic tests if
nonparametric copulas are used, so for this specific application a further research topic is in the use of other
combination functions of the biomarkers than weighted averages. For practical applications, however, one may
wish to stay with functions that lead to a reasonable interpretation of the combination of the biomarkers. It
will be interesting to explore combinations of relatively straightforward combination functions with the use of
nonparametric copulas in our method and investigate the performance of the resulting methods.
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Appendix
Proof
The lower probability for the event T 1n1+1 > T
0
n0+1
, given in Equation (23), is derived as follows
P = P (T 1n1+1 > T
0
n0+1)
=
n1+1X
i=1
n1+1X
l=1
P (T 0n0+1 < X
1
n1+1 + (1  )Y 1n1+1; X1n1+1 2 (x1i 1; x1i ); Y 1n1+1 2 (y1l 1; y1l ))
=
n1+1X
i=1
n1+1X
l=1
P
 
T 0n0+1 < X
1
n1+1 + (1  )Y 1n1+1; (X1n1+1; Y 1n1+1) 2 B1il


n1+1X
i=1
n1+1X
l=1
h1il(^1)P (T
0
n0+1 < t
1
i 1;l 1)
=
n1+1X
i=1
n1+1X
l=1
h1il(^1)
n0+1X
j=1
n0+1X
k=1
P
 
X0n0+1 + (1  )Y 0n0+1 < t1i 1;l 1; (X0n0+1; Y 0n0+1) 2 B0jk


n1+1X
i=1
n1+1X
l=1
h1il(^1)
n0+1X
j=1
n0+1X
k=1
1ft0j;k < t1i 1;l 1gh0jk(^0)
For the lower probability, we want to make the probability for the event T 1n1+1 > T
0
n0+1
as small as possible.
To this end, the first inequality follows by putting the probability h1il(^1) corresponding to the block B
1
il to
the left-bottom of the block, for all i; l = 1; : : : ; n1 + 1. Thus the corresponding combined weighted value is
t1i 1;l 1 = x
1
i 1 + (1  )y1l 1. The second inequality follows by putting the probability h0jk(^0) corresponding to
the block B0jk to the right-top of the block, for all j; k = 1; : : : ; n0 + 1, and the corresponding combined weighted
value is t0j;k = x
0
j + (1  )y0k. Because these configurations of the respective probability masses can actually
be achieved, this is the maximum possible lower bound for the probability of interest and hence it is a lower
probability.
The upper probability for the event T 1n1+1 > T
0
n0+1
, given in Equation (24), is derived as follows
P = P (T 1n1+1 > T
0
n0+1)
=
n1+1X
i=1
n1+1X
l=1
P (T 0n0+1 < X
1
n1+1 + (1  )Y 1n1+1; X1n1+1 2 (x1i 1; x1i ); Y 1n1+1 2 (y1l 1; y1l ))
=
n1+1X
i=1
n1+1X
l=1
P
 
T 0n0+1 < X
1
n1+1 + (1  )Y 1n1+1; (X1n1+1; Y 1n1+1) 2 B1il


n1+1X
i=1
n1+1X
l=1
h1il(^1)P (T
0
n0+1 < t
1
i;l)
=
n1+1X
i=1
n1+1X
l=1
h1il(^1)
n0+1X
j=1
n0+1X
k=1
P
 
X0n0+1 + (1  )Y 0n0+1 < t1i;l; (X0n0+1; Y 0n0+1) 2 B0jk


n1+1X
i=1
n1+1X
l=1
h1il(^1)
n0+1X
j=1
n0+1X
k=1
1ft0j 1;k 1 < t1i;lgh0jk(^0)
For the upper probability, we want to make the probability for the event T 1n1+1 > T
0
n0+1
as large as possible.
To this end, the first inequality follows by putting the probability h1il(^1) corresponding to the block B
1
il to
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the right-top of the block, for all i; l = 1; : : : ; n1 + 1. Thus the corresponding combined weighted value is
t1i;l = x
1
i + (1  )y1l . The second inequality follows by putting the probability h0jk(^0) corresponding to the
block B0jk to the left-bottom of the block, for all j; k = 1; : : : ; n0 + 1, and the corresponding combined weighted
value is t0j 1;k 1 = x
0
j 1 + (1  )y0k 1. This is indeed an upper probability as it is the minimum possible upper
bound for the probability of interest.
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